Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind active-controlled trial of salmeterol/fluticasone inhalation powder in adults with bronchial asthma
CTR20211471Phase 3Active
- Sponsor
- Eddingpharm
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of salmeterol, fluticasone propionate in asthma, sponsored by Eddingpharm. Started Nov 2021; status: active.
02
Drugs
salmeterolfluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20211471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211471.